Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 225 recruiting now early-phase tilt #2 of 28,707 conditions

Healthy: early-phase trial registry

225 of 1,096 indexed Healthy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2 of 28,707 conditions by registered trial count.

1,096 US clinical trials · 225 currently recruiting · #2 of 28,707 conditions by registered trial count

Healthy: 1,096 US clinical trials tracked, 225 recruiting.

Healthy is the subject of 1,096 registered US clinical trials on ClinicalTrials.gov, 225 of them currently open to new participants. 43 are in Phase 3-4 (later-stage) and 546 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 55 of these trials.

Enrollment posture brief

Registry condition healthy

OPEN 225 | RECR 21% | LATE 43 | EARLY 546 | RANK #2 | SPON 55

Nearest open-share peer: Psoriasis (20% recruiting · 127 trials)

Prostate Cancer36.7%Depression35.7%Breast Cancer33.8%Obesity28.9%Healthy (this)21%
Open-enrollment share among volume-matched conditions near Healthy

Healthy lists 225 open slots (21% of 1,096 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Healthy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Healthy is recruiting below its size-band peers.

    225 of 1,096 indexed trials (20.5%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Healthy trials is spread across many organizations.

    Eli Lilly and Company accounts for 55 of 1,096 trials (5%). 429 distinct sponsors appear on at least one study for this condition label.

  3. Most Healthy trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 1,091 trials that report a genuine target (sentinel values excluded). 851 of those (78%) plan for fewer than 100 participants.

  4. Healthy research is mostly interventional.

    905 interventional and 191 observational studies make up this index (82.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 1518Phase 228Phase 311Phase 432

Open and recent trials

1,096 total, page 2 of 22

RECRUITING Phase 1 144 participants

A Study of LY4268989 (MORF-057) in Healthy Participants

Eli Lilly and Company

NCT06964776

RECRUITING NA 142 participants

Hippocampal and Frontoparietal Development and Inference

University of Texas at Austin

NCT07199907

RECRUITING Phase 1 136 participants

A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.

AstraZeneca

NCT06995820

RECRUITING Phase 1 134 participants

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

Eli Lilly and Company

NCT07258849

RECRUITING NA 130 participants

Detection of EEG-Based Biomarkers of Chronic Low Back Pain

Stanford University

NCT06025201

RECRUITING Phase 1 128 participants

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

Eli Lilly and Company

NCT06657768

RECRUITING Phase 1 126 participants

A Study of V118E in Healthy Participants (V118E-003)

Merck Sharp & Dohme

NCT07168915

RECRUITING Phase 1 120 participants

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

University of Alabama at Birmingham

NCT03759522

RECRUITING Phase 1 120 participants

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

Eli Lilly and Company

NCT07044271

RECRUITING NA 120 participants

Testing the Contribution of Orbitofrontal Cortex Networks to Decision-making

Northwestern University

NCT05111223

RECRUITING NA 120 participants

Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease

Masimo Corporation

NCT07223164

RECRUITING Phase 1 120 participants

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

Merck Sharp & Dohme

NCT07388667

RECRUITING Phase 1 120 participants

A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity

Eli Lilly and Company

NCT07232732

RECRUITING NA 120 participants

Cell Free DNA in Cardiac Sarcoidosis

Nabeel Hamzeh

NCT03858777

RECRUITING 120 participants

Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers

National Institute of Allergy and Infectious Diseases (NIAID)

NCT06120244

RECRUITING 114 participants

Influence of Brain Oscillation-Dependent TMS on Motor Function

National Institute of Neurological Disorders and Stroke (NINDS)

NCT03288220

RECRUITING Phase 1 108 participants

The ENHANCE Study: taVNS and Psilocybin

University of Wisconsin, Madison

NCT05866471

RECRUITING Phase 1 104 participants

A Study of LY4088044 in Healthy Participants

Eli Lilly and Company

NCT07090785

RECRUITING 100 participants

Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting

Youngstown State University

NCT07258030

RECRUITING NA 100 participants

Tailoring a Home Supervision Intervention for Latinx Caregivers

Western Michigan University

NCT07203612

RECRUITING 100 participants

Digital Measures for Clinical Trial Endpoints in Huntington's Disease

University of Rochester

NCT07010705

RECRUITING Phase 4 100 participants

The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic Activation

University of Oklahoma

NCT04831398

RECRUITING NA 100 participants

A Study to Evaluate Non-significant Risk Operation Magnetic Resonance Imaging for MRI Guided Ablation

Mayo Clinic

NCT04880226

RECRUITING NA 100 participants

Anti-mullerian Hormone Levels in Healthy Females

Erin Rowell

NCT04537390

RECRUITING NA 100 participants

Non-invasive BCI-controlled Assistive Devices

University of Texas at Austin

NCT05183152

RECRUITING 100 participants

The Gut and Skin Microbiome in Vitiligo Disease Progression

Northwestern University

NCT03577327

RECRUITING NA 100 participants

Post Prandial Individual Responses to Different Foods

Stanford University

NCT06989164

RECRUITING NA 100 participants

Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli

University of Minnesota

NCT06961864

RECRUITING NA 92 participants

NPWT Reduction Mammaplasty

Medstar Health Research Institute

NCT06725459

RECRUITING 91 participants

Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

Dynocardia

NCT04835857

RECRUITING 90 participants

A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease

Mayo Clinic

NCT06057909

RECRUITING 90 participants

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

University of Colorado, Denver

NCT03797183

RECRUITING NA 90 participants

Accuracy Evaluation of the Owlet OSS 3.0-M1 Sensor in Toddlers and Preschoolers

Owlet Baby Care

NCT07321938

RECRUITING Phase 1 90 participants

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

National Institute of Mental Health (NIMH)

NCT07169630

RECRUITING NA 90 participants

Evaluate the Effects of Citicoline on Mood in Healthy Adults

Kirin Holdings Company, Limited

NCT07089238

RECRUITING NA 86 participants

Increasing Physical Activity Through Social Support and Stress Resilience

Arizona State University

NCT06896825

RECRUITING 81 participants

EvaluatIng Normal Values for traditionaL anorectaL fUnction paraMeters With aIr Charged aNd Solid State HRAM catheTErs ("ILLUMINATE" Study)

Laborie Medical Technologies

NCT06805240

RECRUITING 80 participants

Breathing & Blood Pressure

Florida State University

NCT05632406

RECRUITING NA 80 participants

CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study

Mayo Clinic

NCT06220396

RECRUITING NA 80 participants

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

University of Alabama at Birmingham

NCT06989320

RECRUITING NA 80 participants

Imaging Brain Fluids During Breathing

Boston University Charles River Campus

NCT05180981

RECRUITING 80 participants

A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults

Mayo Clinic

NCT06820658

RECRUITING NA 80 participants

Physiology of Human Brain Connectivity

Massachusetts General Hospital

NCT06246942

RECRUITING NA 80 participants

Electrophysiological Source Imaging Guided Transcranial Focused Ultrasound

Carnegie Mellon University

NCT03192436

RECRUITING NA 80 participants

Gut Oxalate Absorption in Calcium Oxalate Stone Disease

University of Alabama at Birmingham

NCT06331546

RECRUITING NA 80 participants

A Mobile App to Improve 24-Hour Movement Guideline Adherence in Preschoolers

University of Kansas Medical Center

NCT06667661

RECRUITING 80 participants

Normative QEEG/ERP Data for Healthy Volunteers

Neuronetrix

NCT05869032

RECRUITING Phase 1 76 participants

A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults

Scholar Rock

NCT07444294

RECRUITING Phase 1 76 participants

A Study of LY3981314 in Healthy Participants

Eli Lilly and Company

NCT07005284

RECRUITING NA 75 participants

Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands

University of California, Davis

NCT04885322

← Previous Page 2 of 22 Next →

Phase Distribution

PhaseTrial count
Phase 1 518
Phase 2 28
Phase 3 11
Phase 4 32

Named interventions

Most-linked intervention names on Healthy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
100 trials
Placebo Other
32 trials
Placebo Dietary supplement
15 trials
Moxifloxacin Drug
9 trials
Midazolam Drug
9 trials
placebo Drug
8 trials
Placebo Biological
7 trials
Omeprazole Drug
6 trials

US sites by state

Facility locations filed on Healthy trials. A trial with sites in several states counts in each.

California 149 trials
Florida 118 trials
Maryland 114 trials
Texas 111 trials
Minnesota 73 trials
Massachusetts 52 trials
Connecticut 49 trials
Pennsylvania 46 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Healthy page

1,096 registered trials, 225 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Healthy condition card totals 1,096 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.